Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V91.1.37PMID 9414267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of Megakaryocytopoiesis by Thrombopoietin : The c-Mpl Ligand

  2000cited by this paper
• Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.

  1997cited by this paper
• Improvement of thrombocytopenia following bone marrow transplantation by pegylated recombinant human megakaryocyte growth and development factor in mice

  1997cited by this paper
• A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization.

  1997cited by this paper
• GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.

  1996cited by this paper
• Synergistic effects of thrombopoietin and granulocyte colony-stimulating factor on neutrophil recovery in myelosuppressed mice.

  1996cited by this paper
• Thrombopoietin Suppresses Apoptosis and Behaves as a Survival Factor for the Human Growth Factor‐Dependent Cell Line, M07e

  1996cited by this paper
• Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.

  1996cited by this paper
• Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy.

  1996cited by this paper
• Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.

  1996cited by this paper
• Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c‐mpl ligand) and the effects of gestational age on frequency of colonies

  1996cited by this paper
• Effects of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor on Thrombocytopenia Induced by a New Myelosuppressive Chemotherapy Regimen in Mice

  1996cited by this paper
• Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.

  1996cited by this paper
• The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells.

  1996cited by this paper
• Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.

  1996cited by this paper
• Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation.

  1996cited by this paper
• Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice.

  1996cited by this paper
• Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3.

  1996cited by this paper
• Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro.

  1996cited by this paper
• In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression.

  1996cited by this paper
• Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice.

  1996cited by this paper
• Effect of recombinant human thrombopoietin in nonhuman primates with chemotherapy‐induced thrombocytopenia

  1996cited by this paper
• A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders

  1996cited by this paper
• Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.

  1996cited by this paper
• In Vivo Effects of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor on Hematopoiesis in Normal Mice

  1996cited by this paper
• Activity of the ligand for c‐mpl, thrombopoietin, in early haemopoiesis

  1996cited by this paper
• The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.

  1995cited by this paper
• Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.

  1995cited by this paper
• Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia.

  1995cited by this paper
• Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.

  1995cited by this paper
• Purification and characterization of thrombopoietin.

  1995cited by this paper
• Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors.

  1995cited by this paper
• Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates.

  1995cited by this paper
• Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy.

  1995cited by this paper
• Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand.

  1995cited by this paper
• Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice.

  1995cited by this paper
• Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice.

  1995cited by this paper
• Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice.

  1995cited by this paper
• A highly sensitive enzyme immunoassay for G-CSF in human plasma.

  1995cited by this paper
• The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production.

  1994cited by this paper
• Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.

  1994cited by this paper
• Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin.

  1994cited by this paper
• Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand

  1994cited by this paper
• Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI

  1994cited by this paper
• Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin

  1994cited by this paper
• Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo

  1994cited by this paper
• A single dose of granulocyte colony-stimulating factor modifies radiation-induced death in B6D2F1 mice.

  1993cited by this paper
• Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa.

  1992cited by this paper
• Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression.

  1991cited by this paper
• Effects of recombinant human granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice.

  1990cited by this paper
• Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor.

  1988cited by this paper
• The megakaryocyte DNA content and platelet formation after the sublethal whole body irradiation of rats

  1984cited by this paper
• The megakaryocyte DNA content and platelet formation after the sublethal whole body irradiation of rats.

  1984cited by this paper
• Cholinesterase as a possible marker for early cells of the megakaryocytic series.

  1973cited by this paper
• A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

  1961cited by this paper

• Novel Small Molecule, UTS-1401, as a Radioprotector for Total-Body Irradiation

  2024cites this paper
• A Mechanism-Based PK/PD Model for Hematological Toxicities Induced by Antibody-Drug Conjugates

  2017cites this paper
• Role of thrombocytopenia in radiation-induced mortality and review of therapeutic approaches targeting platelet regeneration after radiation exposure

  2016cites this paper
• Romiplostim promotes platelet recovery in a mouse model of multicycle chemotherapy-induced thrombocytopenia.

  2015cites this paper
• Single Thrombopoietin Dose Alleviates Hematopoietic Stem Cells Intrinsic Short- and Long-Term Ionizing Radiation Damage. In Vivo Identification of Anatomical Cell Expansion Sites

  2015cites this paper
• Thrombopoietin-increased DNA-PK-dependent DNA repair limits hematopoietic stem and progenitor cell mutagenesis in response to DNA damage.

  2013cites this paper
• long-term follow-up of hematopoiesis after irradiation prevents nonhuman primates from myelosuppression: growth and development factor, and interleukin-3 in combination soon Single administration of stem cell factor, FLT-3 ligand, megakaryocyte

  2013cites this paper
• model of radiation-induced myelosuppression stimulates multilineage hematopoietic recovery in a nonhuman primate Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist,

  2013cites this paper
• Platelets prevent acute hepatitis induced by anti‐fas antibody

  2011cites this paper
• Large-scale transcriptional profiling and functional assays reveal important roles for Rho-GTPase signalling and SCL during haematopoietic differentiation of human embryonic stem cells.

  2011cites this paper
• FUTURE PROSPECT OF THROMBOPOIETIN

  2010cites this paper
• Platelets prevent acute liver damage after extended hepatectomy in pigs

  2010cites this paper
• Myeloprotection following cytotoxic damage: the sooner the better.

  2008cites this paper
• Platelets Promote Liver Regeneration under Conditions of Kupffer Cell Depletion after Hepatectomy in Mice

  2008cites this paper
• Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice

  2008cites this paper
• Single Administration of Thrombopoietin Prevents Progression of Liver Fibrosis and Promotes Liver Regeneration After Partial Hepatectomy in Cirrhotic Rats

  2008cites this paper
• Role of platelets on liver regeneration after 90% hepatectomy in mice.

  2008cites this paper
• Anti-apoptotic peptides protect against radiation-induced cell death.

  2007cites this paper
• CD41+/CD45+ Cells Without Acetylcholinesterase Activity Are Immature and a Major Megakaryocytic Population in Murine Bone Marrow

  2007cites this paper
• Platelets Promote Liver Regeneration in Early Period after Hepatectomy in Mice

  2007cites this paper
• Thrombopoietin Protects Against In Vitro and In Vivo Cardiotoxicity Induced by Doxorubicin

  2006cites this paper
• Acute radiation injury: contingency planning for triage, supportive care, and transplantation.

  2006cites this paper
• [Effects of liquid crystal-related compounds on human megakaryocytopoiesis and thrombopoiesis].

  2006cites this paper
• Soluble factor(s) from bone marrow cells can rescue lethally irradiated mice by protecting endogenous hematopoietic stem cells.

  2005cites this paper
• DEFINING THE FULL THERAPEUTIC POTENTIAL OF RECOMBINANT GROWTH FACTORS IN THE POST RADIATION-ACCIDENT ENVIRONMENT: THE EFFECT OF SUPPORTIVE CARE PLUS ADMINISTRATION OF G-CSF

  2005cites this paper
• Therapeutic Effects of Lycium barbarum Polysaccharide (LBP) on Irradiation or Chemotherapy-Induced Myelosuppressive Mice

  2005cites this paper
• Cytokine-based treatment of accidentally irradiated victims and new approaches.

  2005cites this paper
• Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression: long-term follow-up of hematopoiesis.

  2004cites this paper
• Pegylated recombinant human megakaryocyte growth and development factor suppresses the development of megakaryoblastic leukemia in mice.

  2004cites this paper
• Hematopoietic Growth Factors

  2004cites this paper
• Hematopoietic Recovery Following Autologous Bone Marrow Transplantation in a Nonhuman Primate: Effect of Variation in Treatment Schedule with PEG‐rHuMGDF

  2003cites this paper
• Thrombopoietin is a major limiting factor for selective outgrowth of human umbilical cord blood cells in non‐obese diabetic/severe combined immunodeficient recipient mice

  2003cites this paper
• Marked improvement of thrombocytopenia in a murine model of idiopathic thrombocytopenic purpura by pegylated recombinant human megakaryocyte growth and development factor.

  2002cites this paper
• A functional role of Stat3 in in vivo megakaryopoiesis.

  2002cites this paper
• Use of Filgrastim for Stem Cell Mobilisation and Transplantation in High-Dose Cancer Chemotherapy

  2002cites this paper
• Ticlopidine Inhibits the Prothrombotic Effects of Thrombopoietin and Ameliorates Survival after Supralethal Total Body Irradiation

  2002cites this paper
• Thrombopoietin protects mice from mortality and myelosuppression following high-dose irradiation: importance of time scheduling.

  2002cites this paper
• Effects of the Combination of Thrombopoietin with Cytokines on the Survival of X-Irradiated CD34+ Megakaryocytic Progenitor Cells from Normal Human Peripheral Blood

  2002cites this paper
• Negative Regulation of Platelet Clearance and of the Macrophage Phagocytic Response by the Transmembrane Glycoprotein SHPS-1*

  2002cites this paper
• Promegapoietin‐1a, an Engineered Chimeric IL‐3 and Mpl‐L Receptor Agonist, Stimulates Hematopoietic Recovery in Conventional and Abbreviated Schedules Following Radiation‐Induced Myelosuppression in Nonhuman Primates

  2001cites this paper
• Platelets Exposed to Elevated Levels of Endogenous Thrombopoietin In Vivo Have a Reduced Response to Megakaryocyte Growth and Development Factor In Vitro

  2001cites this paper
• Leridistim, a Chimeric Dual G‐CSF and IL‐3 Receptor Agonist, Enhances Multilineage Hematopoietic Recovery in a Nonhuman Primate Model of Radiation‐Induced Myelosuppression: Effect of Schedule, Dose, and Route of Administration

  2001cites this paper
• Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality.

  2001cites this paper
• A schedule of recombinant Mpl ligand highly effective at preventing lethal myelosuppression in mice given carboplatin and radiation.

  2001cites this paper
• Expression of thrombopoietin by umbilical vein endothelial cells.

  2001cites this paper
• Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis.

  2001cites this paper
• Use of thrombopoietic growth factors in acute leukemia

  2000cites this paper
• Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.

  2000cites this paper
• Lack of efficacy of thrombopoietin and granulocyte-macrophage colony-stimulating factor after total body irradiation and autologous bone marrow transplantation in Rhesus monkeys.

  2000cites this paper
• Thrombopoietin.

  1999cites this paper
• Development of Thrombopoietin: Its Structure and Function

  1999cites this paper
• PEG-rHuMGDF promotes multilineage hematopoietic recovery in myelosuppressed mice.

  1999cites this paper
• Pharmacokinetics and Hematological Effects of the PEGylated Thrombopoietin Peptide Mimetic GW395058 in Rats and Monkeys After Intravenous or Subcutaneous Administration

  1999cites this paper
• Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation.

  1999cites this paper
• Interaction of thrombopoietin with the platelet c‐mpl receptor in plasma: binding, internalization, stability and pharmacokinetics

  1999cites this paper
• The enigmatic megakaryocyte gradually reveals its secrets.

  1999cites this paper
• Immunogenicity of Thrombopoietin Mimetic Peptide GW395058 in BALB/c Mice and New Zealand White Rabbits: Evaluation of the Potential for Thrombopoietin Neutralizing Antibody Production in Man

  1999cites this paper
• Thrombopoietin: biology and clinical potentials.

  1999cites this paper
• The combined administration of daniplestim and mpl ligand augments the hematopoietic reconstitution observed with single cytokine administration in a nonhuman primate model of myelosuppression

  1998cites this paper
• A Single Dose of Thrombopoietin Shortly After Myelosuppressive Total Body Irradiation Prevents Pancytopenia in Mice by Promoting Short-Term Multilineage Spleen-Repopulating Cells at the Transient Expense of Bone Marrow–Repopulating Cells

  1998cites this paper
• Mobilization of primitive haemopoietic progenitor cells and stem cells with long‐term repopulating ability into peripheral blood in mice by pegylated recombinant human megakaryocyte growth and development factor

  1998cites this paper
• Thrombopoietin.

  1998cites this paper
• New insights into the regulation of megakaryocyte differentiation and platelet production derived from cloning of thrombopoietin and its receptor: surprises and unresolved questions as thrombopoietin proceeds through clinical trials.

  1998cites this paper
• Native Thrombopoietin: Structure and Function

  1998cites this paper
• The Efficacy of Recombinant Thrombopoietin in Murine and Nonhuman Primate Models for Radiation‐Induced Myelosuppression and Stem Cell Transplantation

  1998cites this paper
• Thrombopoietin: its role in platelet disorders and as a new drug in clinical medicine.

  1998cites this paper
• A single dose of thrombopoietin shortly after myelosuppressive total body irradiation prevents pancytopenia in mice by promoting short-term multilineage spleen-repopulating cells at the transient expense of bone marrow-repopulating cells.

  1998cites this paper
• Thrombopoietin: a preclinical evaluation

  1998cites this paper
• The efficacy of recombinant tpo in murine and nonhuman primate models for myelosuppression and stem cell transplantation

  1998cites this paper
• Thrombocytopenia-Platelet Support or Growth Factors?

  1998cites this paper
• Overview of the safety and biologic effects of peg‐rhumgdf in clinical trials

  1998cites this paper